CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...